COX5B and glioblastoma: On the other hand, COX5B expression was decreased in breast cancer, colon cancer, clear cell renal cell carcinoma (RCC), pancreatic adenocarcinoma (PAAD), head and neck cancers, glioblastoma, and liver cancer (Fig. S1B).